James A Geraghty bought $1 of PVLA
director at PALVELLA THERAPEUTICS, INC.. 1 shares at an average of $1.00, traded Aug 7, 2024, filed Oct 28, 2024.
Score components
- +15RoleDirector
- 0Trade size$1 at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -1.0%, 3m -24.1%, 6m +44.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-24-032319, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 7, 2024 | POpen-market purchase Series F Preferred Stock, par value $0.001 per share | +1 | $1.00 | $1 | 1 | Oct 28, 2024 |
Related signals
Other insiders at PALVELLA THERAPEUTICS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | PALVELLA THERAPEUTICS, INC. | Kathleen Goin Chief Operating Officer | $655k 4,302 shares | -100% | |
| 40Moderate | PALVELLA THERAPEUTICS, INC. | George M Jenkins director | $4.2M 27,500 shares | -15% | |
| 42Moderate | PALVELLA THERAPEUTICS, INC. | Christopher P Kiritsy director | $49k 313 shares | -56% | |
| 21Weak | PALVELLA THERAPEUTICS, INC. | Kathleen Goin Chief Operating Officer | $415k 4,302 shares | -100% | |
| 20Weak | PALVELLA THERAPEUTICS, INC. | Kathleen Goin Chief Operating Officer | $371k 4,302 shares | -100% | |
| 29Weak | PVLAbuy PALVELLA THERAPEUTICS, INC. | George M Jenkins director | $101k 4,990 shares | +3% | |
| 22Weak | PVLAbuy PALVELLA THERAPEUTICS, INC. | George M Jenkins director | $52k 4,000 shares | +2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.